×
About 133 results

ALLMedicine™ Pineal Tumors Center

Research & Reviews  48 results

Pineal Tumors
http://emedicine.medscape.com/article/249945-overview

Aug 8th, 2022 - Practice Essentials Anatomy and pathophysiology The pineal gland develops during the second month of gestation as a diverticulum in the diencephalic roof of the third ventricle. It is flanked by the posterior and habenular commissures in the rostr...

Pineal Tumors
https://emedicine.medscape.com/article/249945-print

Aug 8th, 2022 - Practice Essentials Anatomy and pathophysiology The pineal gland develops during the second month of gestation as a diverticulum in the diencephalic roof of the third ventricle. It is flanked by the posterior and habenular commissures in the rostr...

Pineal Tumors
https://emedicine.medscape.com/article/249945-overview

Aug 8th, 2022 - Practice Essentials Anatomy and pathophysiology The pineal gland develops during the second month of gestation as a diverticulum in the diencephalic roof of the third ventricle. It is flanked by the posterior and habenular commissures in the rostr...

Pediatric pineal region masses: a single-center experience over 25 years.
https://doi.org/10.1007/s00381-022-05593-6
Child's Nervous System : ChNS : Official Journal of the I... Malik N, Samples DC et. al.

Jul 14th, 2022 - Pineal region tumors (PRT) represent less than 1% of brain neoplasms. The rare and heterogeneous nature of these tumors is reflected in the variety of treatment modalities employed. A single-center retrospective review of all pediatric patients wi...

Staged operations for a hypervascular mixed germ cell tumor with growing teratoma syndr...
https://doi.org/10.1007/s00381-021-05393-4
Child's Nervous System : ChNS : Official Journal of the I... Jung TY, Baek HJ et. al.

Nov 11th, 2021 - A mixed germ cell tumor with a teratoma component can become enlarged following chemotherapy, and such an event is diagnosed as growing teratoma syndrome. Removing large, hypervascular tumors including a tumor encased by developed vasculatures fro...

see more →

Clinicaltrials.gov  5 results

A Phase I Study of Pazopanib as a Single Agent for Children With Refractory Solid Tumors
https://clinicaltrials.gov/ct2/show/NCT01130623

Jul 2nd, 2017 - Background: Pazopanib is a potent and selective multi-target receptor tyrosine kinase inhibitor of vascular endothelial growth factor (VEGF) receptors (VEGFR)-1, -2, and -3, c-kit and platelet derived growth factor (PDGF) receptors-alpha and -beta...

A Phase I Study of Vorinostat and Bortezomib in Children With Refractory of Recurrent Solid Tumors, Including CNS Tumors and Lymphomas
https://clinicaltrials.gov/ct2/show/NCT01132911

Jul 2nd, 2017 - Background: -The combination of vorinostat and bortezomib has been shown to be synergistic in vitro in a variety of malignancies, including hepatoma, multiple myeloma, leukemia, lymphoma, and gastrointestinal cancer. Currently several phase 2 adul...

A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors
https://clinicaltrials.gov/ct2/show/NCT01182883

Jul 2nd, 2017 - Background IMC-A12 is a fully recombinant IgG1monoclonal antibody to the insulin-like growth factor receptor (IGFR). It acts as an antagonist of IGF-1 and IGF-2 ligand binding and blocks ligand binding to IGF-1R and inhibits downstream signaling o...

Combination Chemotherapy, Surgery or Radiation Therapy, and Peripheral Stem Cell Transplant in Treating Patients With Recurrent Medulloblastoma or Primitive Neuroectodermal and Pineal Tumors
https://clinicaltrials.gov/ct2/show/NCT00025077

Aug 2nd, 2013 - OBJECTIVES: Determine the feasibility of cyclophosphamide and surgical resection or radiotherapy followed by thiotepa, carboplatin, and autologous peripheral blood stem cell rescue in patients with recurrent medulloblastoma or supratentorial neuro...

Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors
https://clinicaltrials.gov/ct2/show/NCT00002463

Feb 18th, 2013 - OBJECTIVES: I. Determine the efficacy of high-dose methotrexate (HMTX) in combination with mechlorethamine, vincristine, prednisone, and procarbazine (MOPP) in infants or young children with primitive neuroectodermal tumors (PNET) (including medul...

see more →